- LENLennar$22.1BReported
LENQ4 2016
Lennar
View full reportEPS
Estimated
$1.29
Actual
$1.343.9%
Revenue
Estimated
$3.2B
Actual
$3.4B4.0%
- WORWorthington$2.8BReported
WORQ2 2017
Worthington
View full reportEPS
Estimated
$0.83
Actual
$0.759.6%
Revenue
Estimated
$797.9M
Actual
$727.8M8.8%
- FDXFedEx$98.2BReported
FDXQ2 2017
FedEx
View full reportEPS
Estimated
$2.90
Actual
$2.803.4%
Revenue
Estimated
$15.5B
Actual
$14.9B3.4%
- NKENike$70.1BReported
NKEQ2 2017
Nike
View full reportEPS
Estimated
$0.43
Actual
$0.5016.3%
Revenue
Estimated
$6.8B
Actual
$8.2B19.4%
- CCLCarnival$34.6BReported
CCLQ4 2016
Carnival
View full reportEPS
Estimated
$0.58
Actual
$0.6715.5%
Revenue
Estimated
$3.3B
Actual
$3.9B18.4%
- DRIDarden$23.4BReported
DRIQ2 2017
Darden
View full reportEPS
Estimated
$0.64
Actual
$0.640.0%
Revenue
Estimated
$1.6B
Actual
$1.6B0.0%
- GISGeneral Mills$18.1BReported
GISQ2 2017
General Mills
View full reportEPS
Estimated
$0.86
Actual
$0.851.2%
Revenue
Estimated
$4.2B
Actual
$4.1B1.2%
- FDSFactSet$8.7BReported
FDSQ1 2017
FactSet
View full reportEPS
Estimated
$1.70
Actual
$1.752.9%
Revenue
Estimated
$279.6M
Actual
$288.1M3.0%
- VALValaris$6.4BReported
VALQ4 2016
Valaris
View full reportEPS
Estimated
$1.50
Actual
$1.378.7%
Revenue
Estimated
$1.2B
Actual
$1.1B5.5%
- KMXCarMax$6.2BReported
KMXQ3 2017
CarMax
View full reportEPS
Estimated
$0.70
Actual
$0.722.9%
Revenue
Estimated
$3.6B
Actual
$148.6M95.9%
- BBBlackBerry$5.1BReported
BBQ3 2017
BlackBerry
View full reportEPS
Estimated
$0.00
Actual
$0.02373.9%
Revenue
Estimated
$1.0B
Actual
$301.0M71.1%
- SCSSteelcase$1.9BReported
SCSQ3 2017
Steelcase
View full reportEPS
Estimated
$0.31
Actual
$0.310.0%
Revenue
Estimated
$786.5M
Actual
$786.5M0.0%
- EBFEnnis$520MReported
EBFQ3 2016
Ennis
View full reportEPS
Estimated
$0.36
Actual
$0.2725.0%
Revenue
Estimated
$85.6M
Actual
$88.7M3.6%
- CVGWCalavo Growers$466MReported
CVGWQ4 2016
Calavo Growers
View full reportEPS
Estimated
$0.48
Actual
$0.5310.4%
Revenue
Estimated
$224.3M
Actual
$247.7M10.4%
- NNDMNano Dimension$354MReported
NNDMQ3 2016
Nano Dimension
View full reportEPS
Estimated
-$2.20
Actual
-$2.5013.6%
Revenue
Estimated
—
Actual
—
- MUMicron$1.04TReported
MUQ1 2017
Micron
View full reportEPS
Estimated
$0.28
Actual
$0.3214.3%
Revenue
Estimated
$4.0B
Actual
$4.0B0.5%
- ACNAccenture$110BReported
ACNQ1 2017
Accenture
View full reportEPS
Estimated
$1.49
Actual
$1.586.0%
Revenue
Estimated
$8.5B
Actual
$9.0B6.0%
- PAYXPaychex$34.2BReported
PAYXQ2 2017
Paychex
View full reportEPS
Estimated
$0.55
Actual
$0.561.8%
Revenue
Estimated
$771.4M
Actual
$771.4M0.0%
- AIRAAR Corp$4.6BReported
AIRQ2 2017
AAR Corp
View full reportEPS
Estimated
$0.35
Actual
$0.350.0%
Revenue
Estimated
$423.8M
Actual
$423.8M0.0%
- NEOGNeogen$2.0BReported
NEOGQ2 2017
Neogen
View full reportEPS
Estimated
$0.10
Actual
$0.1550.0%
Revenue
Estimated
$82.5M
Actual
$90.7M10.0%
- EPACEnerpac$1.7BReported
EPACQ1 2017
Enerpac
View full reportEPS
Estimated
$0.17
Actual
$0.2017.6%
Revenue
Estimated
$218.9M
Actual
$265.8M21.4%
- LNNLindsay$1.1BReported
LNNQ1 2017
Lindsay
View full reportEPS
Estimated
$0.61
Actual
$0.0886.9%
Revenue
Estimated
$841.8M
Actual
$110.4M86.9%
- MLKNMillerKnoll$1.1BReported
MLKNQ2 2017
MillerKnoll
View full reportEPS
Estimated
$0.54
Actual
$0.540.0%
Revenue
Estimated
$594.0M
Actual
$577.5M2.8%
- WGOWinnebago$857MReported
WGOQ1 2017
Winnebago
View full reportEPS
Estimated
$0.35
Actual
$0.328.6%
Revenue
Estimated
$181.1M
Actual
$245.3M35.5%
- CTASCintas$69.2BReported
CTASQ2 2017
Cintas
View full reportEPS
Estimated
$0.29
Actual
$0.290.0%
Revenue
Estimated
$1.3B
Actual
$1.3B1.7%
- CAGConAgra$6.4BReported
CAGQ2 2017
ConAgra
View full reportEPS
Estimated
$0.45
Actual
$0.498.9%
Revenue
Estimated
$1.9B
Actual
$2.1B9.7%
- CALMCal-Maine Foods$3.6BReported
CALMQ2 2017
Cal-Maine Foods
View full reportEPS
Estimated
-$0.48
Actual
-$0.480.0%
Revenue
Estimated
$253.5M
Actual
$253.5M0.0%
- NOTVInotiv$9.9MReported
NOTVQ4 2016
Inotiv
View full reportEPS
Estimated
$0.00
Actual
-$0.13
Revenue
Estimated
$0.00
Actual
$5.2M
- HRTXHeron Therapeutics$169MReported
HRTXQ3 2016
Heron Therapeutics
View full reportEPS
Estimated
-$1.14
Actual
-$1.248.8%
Revenue
Estimated
—
Actual
$661.0K